Association between metabolic syndrome and oral pre-malignancy: A community- and population-based study (KCIS No. 28)

被引:11
作者
Yen, Amy Ming-Fang [2 ]
Chen, Sam Li-Sheng [2 ]
Chiu, Sherry Yueh-Hsia [3 ,4 ]
Chen, Hsiu-Hsi [1 ]
机构
[1] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Div Biostat, Taipei 100, Taiwan
[2] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan
[3] Chang Gung Univ, Dept Hlth Care Management, Tao Yuan, Taiwan
[4] Chang Gung Univ, Grad Inst Hlth Care Management, Tao Yuan, Taiwan
关键词
Oral pre-malignancy; Metabolic syndrome; Risk factors; Leukoplakia; Oral submucous fibrosis; Erythroleukoplakia; Community; Population-based; NECROSIS-FACTOR-ALPHA; BETEL-QUID; CARDIOVASCULAR-DISEASE; PERIODONTAL-DISEASE; SUBMUCOUS FIBROSIS; DIABETES-MELLITUS; NATURAL-HISTORY; FOLLOW-UP; LEUKOPLAKIA; TRANSFORMATION;
D O I
10.1016/j.oraloncology.2011.04.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To elucidate the effect of metabolic syndrome (MetS) on oral pre-malignancy (OPM) and also to examine whether the effect is independent of areca nut chewing. We enrolled a total of 79,940 subjects aged 20 years or older undergoing both oral mucous examination and health check-up for MetS within the Keelung Community-based Integrated Screening program between 2003 and 2008. We identified 368 leukoplakia, 72 erythroleukoplakia, and 69 oral submucous fibrosis. The multi-variable logistic regression was used to assess the association between MetS and OPM with adjustment of age, gender, areca nut chewing, smoking, and alcohol drinking. Subjects with MetS were at increased risk for OPM (adjusted odds ratio (aOR) = 1.68, 95% confidence interval (CI): 1.39-2.04) compared with those without MetS after taking all explanatory factors into account. Among the five components of MetS, subjects with hypertriglyceride (aOR = 1.43, 95% CI: 1.17-1.75) and hyperglycemia (aOR = 1.30, 95% CI: 1.02-1.67) had higher risk of presenting OPM compared with those within normal ranges. The association between MetS and OPM still persisted even in non-chewers (aOR = 1.85, 95% CI: 1.42-2.40) while other risk factors were controlled. We demonstrate a positive association between MetS and OPM, which is independent of areca nut chewing and other confounding factors. This finding provides an insight into a new direction of preventing OPM in contrast to conventional viewpoint focusing on the most important factor of area nut chewing. (C) 2011 Published by Elsevier Ltd.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 36 条
[1]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]  
BONNERWEIR S, 1988, LESSONS ANIMAL DIABE, V2
[3]   Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective [J].
Bradham, WS ;
Bozkurt, B ;
Gunasinghe, H ;
Mann, D ;
Spinale, FG .
CARDIOVASCULAR RESEARCH, 2002, 53 (04) :822-830
[4]   Community-based multiple screening model - Design, implementation, and analysis of 42,387 participants Taiwan community-based integrated screening group [J].
Chen, THH ;
Chiu, YH ;
Luh, DL ;
Yen, MF ;
Wu, HM ;
Chen, LS ;
Tung, TH ;
Huang, CC ;
Chan, CC ;
Shiu, MN ;
Yeh, YP ;
Liou, HH ;
Liao, CS ;
Lai, HC ;
Chiang, CP ;
Peng, HL ;
Tseng, CD ;
Yen, MS ;
Hsu, WC ;
Chen, CH .
CANCER, 2004, 100 (08) :1734-1743
[5]   Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan [J].
Chiang, CP ;
Wu, HY ;
Liu, BY ;
Wang, JT ;
Kuo, MYP .
ORAL ONCOLOGY, 2002, 38 (01) :56-63
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Clinical risk factors of oral leukoplakia in a representative sample of the US population [J].
Dietrich, T ;
Reichart, PA ;
Scheifele, C .
ORAL ONCOLOGY, 2004, 40 (02) :158-163
[8]   Association between diabetes mellitus and pre-malignant oral diseases: A cross sectional study in Kerala, India [J].
Dikshit, RP ;
Ramadas, K ;
Hashibe, M ;
Thomas, G ;
Somanathan, T ;
Sankaranarayanan, R .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (02) :453-457
[9]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[10]  
EINHORN J, 1967, CANCER-AM CANCER SOC, V20, P2189, DOI 10.1002/1097-0142(196712)20:12<2189::AID-CNCR2820201218>3.0.CO